8-K: Nordson Corporation Reports 4% Sales Increase in First Quarter, Narrows Full-Year Guidance

Nordson Corporation announced a 4% increase in sales for the first quarter of fiscal year 2024, driven by acquisitions and growth in certain segments, while also narrowing its full-year guidance.

Summary

• Nordson Corporation reported a 4% increase in sales to $633 million for the first quarter of fiscal year 2024, compared to $610 million in the same period last year.
• This increase includes a 5% positive impact from acquisitions, partially offset by a 2% decrease in organic sales.
• The organic sales decline was primarily due to weakness in electronics product lines, while medical interventional, industrial, and polymer processing product lines showed growth.
• Net income for the quarter was $110 million, or $1.90 per diluted share, compared to $104 million, or $1.81 per diluted share, in the prior year.
• Adjusted earnings per diluted share were $2.21, a 3% increase from $2.14 in the prior year.
• EBITDA for the quarter was $197 million, or 31% of sales, compared to $181 million, or 30% of sales, in the prior year.
• The company is narrowing its full-year revenue growth guidance to 4% to 7% over fiscal 2023 and adjusted earnings per diluted share to a range of $10.00 to $10.50.
• Second quarter fiscal 2024 sales are forecasted in the range of $645 to $670 million with adjusted earnings in the range of $2.20 to $2.35 per diluted share.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive due to the overall sales growth and strong performance in certain segments, despite some weakness in electronics. The narrowing of guidance suggests confidence in the company's outlook.

Positives

• The company experienced a 4% increase in overall sales, demonstrating growth.
• The Industrial Precision Solutions segment showed strong growth, driven by acquisitions and organic sales.
• The Medical and Fluid Solutions segment also saw growth, particularly in medical interventional solutions.
• EBITDA increased by 9% year-over-year, driven by higher operating profit and improved gross margins.
• Adjusted earnings per diluted share increased by 3% year-over-year.
• The company's backlog remains strong at approximately $750 million.

Negatives

• Organic sales decreased by 2% due to weakness in electronics product lines.
• The Advanced Technology Solutions segment experienced an 18% sales decrease due to weakness in the electronics market.
• The company is facing ongoing pressure in electronics product lines.

Risks

• The company is facing ongoing weakness in the electronics end market, impacting the Advanced Technology Solutions segment.
• The company's future performance is subject to various risks and uncertainties, including economic conditions, currency exchange rates, and possible acquisitions.
• The company is unable to reconcile its adjusted earnings guidance to a comparable GAAP range due to the unpredictability of future adjustments.

Future Outlook

The company has narrowed its full-year revenue growth guidance to 4% to 7% over fiscal 2023 and adjusted earnings per diluted share to a range of $10.00 to $10.50. Second quarter fiscal 2024 sales are forecasted in the range of $645 to $670 million with adjusted earnings in the range of $2.20 to $2.35 per diluted share.

Management Comments

• Sales results were in line with our first quarter expectations.
• The segments delivered a strong operating performance exceeding our first quarter earnings guidance.
• This is a great example of our entrepreneurial teams using NBS Next to meet the needs of our customers, while also taking strategic actions that position them for future profitable growth.
• I am particularly pleased with the solid performance of our IPS and MFS segments during the quarter, while ATS continued to manage the ongoing weakness of the electronics end market.
• The ARAG acquisition integration continued to make steady progress and contributed to our sales and EBITDA margin performance in the quarter.

Industry Context

The results reflect a mixed performance across different sectors, with strength in industrial and medical solutions offsetting weakness in electronics, which aligns with current trends in the broader technology and manufacturing industries.

Comparison to Industry Standards

• Nordson's 4% sales growth is moderate compared to some high-growth technology companies but is solid for a diversified industrial manufacturer.
• The 31% EBITDA margin is strong and indicates efficient operations, potentially outperforming some peers in the industrial sector.
• The company's performance in medical solutions is in line with the growing demand in the healthcare industry.
• The weakness in electronics is a common challenge for many companies in the current market, and Nordson's response is consistent with industry trends.

Stakeholder Impact

• Shareholders will likely react positively to the sales growth and narrowed guidance.
• Employees may be impacted by the performance of different segments, with potential growth in some areas and challenges in others.
• Customers will benefit from the company's continued focus on innovation and solutions.
• Suppliers may see increased demand in certain areas and decreased demand in others.

Next Steps

• The company will provide additional commentary on the results during a webcast on February 22, 2024.
• The company will continue to focus on integrating the ARAG acquisition and managing the weakness in the electronics market.

Key Dates

Keywords

Nordson, sales, EBITDA, earnings, guidance, acquisitions, organic sales, Industrial Precision Solutions, Medical and Fluid Solutions, Advanced Technology Solutions, electronics, medical, industrial, polymer processing